Assetmark, Inc Standard Biotools Inc. Transaction History
Assetmark, Inc
- $36.4 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding LAB
# of Institutions
143Shares Held
274MCall Options Held
6.7KPut Options Held
48.7K-
Casdin Capital, LLC New York, NY71.3MShares$86.2 Million10.73% of portfolio
-
Viking Global Investors LP58.7MShares$71 Million0.35% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$26.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$20.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY16.9MShares$20.4 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $95.2M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...